This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

Sexual & Reproductive Health

We develop and advance woman-centered contraceptive technologies; empower women and girls with knowledge to take control of their own sexual and reproductive health; and work to increase access to affordable, high-quality reproductive health supplies.

Our Work
Articles from our global team
97 Articles
97 Articles
97 Articles
  1. Pregnant women exercise outside the Lugbe Primary Heath Care Center at the start of antenatal clinic. Abuja, Africa
    November 12, 2018

    Empowering women and girls to define their sexual and reproductive health

    Supporting the health and well-being of women and girls everywhere is at PATH’s core. Martha Brady, director of our Sexual and Reproductive Health program, writes about the innovative work her team is doing to help empower half the world’s population.

  2. Woman holds subcutaneous DMPA (DMPA-SC, Sayana Press)
    September 12, 2018

    The power to prevent pregnancy in women’s hands: DMPA-SC injectable contraception

    Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC (brand name Sayana® Press), an all-in-one contraceptive that puts women in charge of their reproductive health.

  3. Women holding careHPV self-sampling brush
    July 1, 2018

    Target: elimination of cervical cancer

    Over the past three decades PATH has witnessed dramatic changes in attitudes about cervical cancer control.

  4. Family planning provider training in Uganda
    June 18, 2018

    Training for DMPA-SC, the all-in-one injectable contraceptive

    Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.

  5. A woman self-injects the contraceptive, subcutaneous DMPA (DMPA-SC). PATH/Gabe Bienczycki
    June 18, 2018

    Self-injection best practices: Designing family planning programs that work

    Research in Uganda and elsewhere shows that women can self-administer DMPA-SC safely and effectively, that they like doing so, and that self-injection helps support continued use of injectable contraception.

  6. Community health worker holds subcutaneous DMPA device (DMPA-SC, Sayana Press)
    June 18, 2018

    Practical guidance for DMPA-SC introduction and scale-up

    Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.

Load more